Home > Annual Financials > GUFIC BIOSCIENCES

GUFIC BIOSCIENCES Financial Statement Analysis
[BOM: 509079|NSE : GUFICBIO]

The Revenues of GUFIC BIOSCIENCES have increased by 15.15% YoY .
The Earnings Per Share (EPS) of GUFIC BIOSCIENCES has decreased by -7.91 % YoY.
COMMUNITY POLL
for GUFIC BIOSCIENCES
Please provide your vote to see the results

GUFIC BIOSCIENCES Last 5 Annual Financial Results
[BOM: 509079|NSE : GUFICBIO]

ConsolidatedMar2026
Mar2025
Mar2024
Revenues ₹944 Cr₹820 Cr₹807 Cr
Expenses ₹793 Cr₹684 Cr₹659 Cr
Operating Profit (Excl OI) ₹151 Cr₹136 Cr₹147 Cr
Other Income ₹2.66 Cr₹3.63 Cr₹2.18 Cr
Interest ₹37 Cr₹25 Cr₹17 Cr
Depreciation ₹31 Cr₹21 Cr₹17 Cr
Profit Before Tax ₹87 Cr₹94 Cr₹116 Cr
Profit After Tax ₹64 Cr₹70 Cr₹86 Cr
Consolidated Net Profit ₹64 Cr₹70 Cr₹86 Cr
Earnings Per Share (Rs)₹6.40₹6.95₹8.59
PAT Margin (%)5.256.339.16
ROE(%)10.1412.2916.17
ROCE(%)12.5613.4815.59
Total Debt/Equity(x)0.580.520.60

Key Financials

Market Cap : ₹ 4,192.0 Cr
Revenue (TTM) : ₹ 981.1 Cr
Net Profit(TTM) : ₹ 73.5 Cr
EPS (TTM) : ₹ 7.3
P/E (TTM) : 57.1

Industry Peers & Returns1W1M1Y
GUFIC BIOSCIENCES -0.6% 10.5% 19.3%
SUN PHARMACEUTICAL INDUSTRIES 1.8% -1.6% 16.5%
DIVIS LABORATORIES -1.2% 17.3% 38.7%
TORRENT PHARMACEUTICALS -2.3% -2% 33.6%
CIPLA 0.2% 1.7% -8.8%
DR REDDYS LABORATORIES 1.2% 3.6% -7%
MANKIND PHARMA -0.6% -5.2% -4%
LUPIN -1.6% -7.6% 11.4%
ZYDUS LIFESCIENCES -1.4% -0.7% 13.5%


GUFIC BIOSCIENCES Revenues
[BOM: 509079|NSE : GUFICBIO]

Y-o-Y

15.15 %

5 Yr CAGR

8.18 %

Years Revenues % Change
Mar2026 ₹944 Cr
15.15
Mar2025 ₹820 Cr
1.63
Mar2024 ₹807 Cr -


GUFIC BIOSCIENCES Operating Profit
[BOM: 509079|NSE : GUFICBIO]

Y-o-Y

11.19 %

5 Yr CAGR

1.36 %

Years Operating Profit % Change
Mar2026 ₹151 Cr
11.19
Mar2025 ₹136 Cr
-7.60
Mar2024 ₹147 Cr -

Operating Margins
Y-o-Y

-3.43 %

5 Yr CAGR

-6.31 %

Years Operating Margin% % Change
Mar2026 16.03%
-3.43
Mar2025 16.6%
-9.09
Mar2024 18.26% -

GUFIC BIOSCIENCES Profit After Tax
[BOM: 509079|NSE : GUFICBIO]

Y-o-Y

-7.80 %

5 Yr CAGR

-13.66 %

Years Profit After Tax % Change
Mar2026 ₹64 Cr
-7.80
Mar2025 ₹70 Cr
-19.14
Mar2024 ₹86 Cr -

PAT Margins
Y-o-Y

-17.06 %

5 Yr CAGR

-24.29 %

Years PAT Margin(%) % Change
Mar2026 5.25 %
-17.06
Mar2025 6.33 %
-30.90
Mar2024 9.16 % -

GUFIC BIOSCIENCES Earnings Per Share (EPS)
[BOM: 509079|NSE : GUFICBIO]

Y-o-Y

-7.91 %

5 Yr CAGR

-13.68 %

Years EPS % Change
Mar2026 ₹6.40
-7.91
Mar2025 ₹6.95
-19.09
Mar2024 ₹8.59 -

GUFIC BIOSCIENCES Return on Capital Employed (ROCE)
[BOM: 509079|NSE : GUFICBIO]

Y-o-Y

-6.82 %

5 Yr CAGR

-10.24 %

Years ROCE % Change
Mar2026 12.56%
-6.82
Mar2025 13.48%
-13.53
Mar2024 15.59% -

GUFIC BIOSCIENCES Share Price vs Sensex

Current Share Price : ₹418.0
Current MarketCap: ₹ 4,192.0 Cr
Updated EOD on :Aug 24,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
GUFIC BIOSCIENCES

-0.6%

10.5%

19.3%

SENSEX

-0.5%

1.3%

-4%

GUFIC BIOSCIENCES related INDICES

BSE Indices1W1M1Y
BSE HEALTHCARE -0.2% 2.1% 13.8%
BSE 1000 -0.3% 2.5% 4%
No NSE index found

You may also like the below Video Courses


FAQ about GUFIC BIOSCIENCES Financials


How the annual revenues of GUFIC BIOSCIENCES have changed ?

The Revenues of GUFIC BIOSCIENCES have increased by 15.15% YoY .

How the Earnings per Share (EPS) of GUFIC BIOSCIENCES have changed?

The Earnings Per Share (EPS) of GUFIC BIOSCIENCES has decreased by -7.91 % YoY .